{{Rsnum
|rsid=1079596
|Gene=DRD2
|Chromosome=11
|position=113425897
|Orientation=minus
|GMAF=0.2332
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
|Gene_s=DRD2
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 4.6 | 24.6 | 70.8
| HCB | 22.7 | 54.5 | 22.7
| JPT | 13.6 | 56.8 | 29.5
| YRI | 0.0 | 38.1 | 61.9
| ASW | 0.0 | 0.0 | 0.0
| CHB | 22.7 | 54.5 | 22.7
| CHD | 0.0 | 0.0 | 0.0
| GIH | 0.0 | 0.0 | 0.0
| LWK | 0.0 | 0.0 | 0.0
| MEX | 0.0 | 0.0 | 0.0
| MKK | 0.0 | 0.0 | 0.0
| TSI | 0.0 | 0.0 | 0.0
| HapMapRevision=28
}}{{PMID Auto GWAS
|PMID=17903293
|Trait=Select biomarker traits
|Title=Genome-wide association with select biomarker traits in the Framingham Heart Study
|RiskAllele=
|Pval=0.0000030000000000000001
|OR=NR
|ORtxt=NR
|OA=1
}}

{{PMID Auto
|PMID=18821566
|Title=SNPs in dopamine D2 receptor gene (DRD2) and norepinephrine transporter gene (NET) are associated with continuous performance task (CPT) phenotypes in ADHD children and their families.
|OA=1
}}

{{PMID Auto
|PMID=19968402
|Title=Evaluation of genetic variability in the dopamine receptor D2 in relation to behavioral inhibition and impulsivity/sensation seeking: an exploratory study with d-amphetamine in healthy participants.
|OA=1
}}

{{GET Evidence
|impact=pathogenic
|qualified_impact=Insufficiently evaluated pathogenic
|inheritance=unknown
|quality_scores=Array
|dbsnp_id=rs1079596
|overall_frequency_n=34
|overall_frequency_d=128
|overall_frequency=0.265625
|n_genomes=22
|n_genomes_annotated=0
|n_haplomes=27
|n_articles=0
|n_articles_annotated=0
|in_gwas=Y
|autoscore=1
|webscore=N
}}

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}